Federal Register / Vol. 63, No. 105 /Tuesday, June 2, 1998 / Notices 30001

Management Specialist, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), 255 East

Paces Ferry Road, NE, Room 321,

Atlanta, GA 30305, on or before July 15,

1998.

1. Deadline: Applications will be

considered as meeting the deadline if

they are either:

(a) Received on or before the deadline

date, or

(b) Sent on or before the deadline date

and received in time for submission to

the objective review group. (The

applicants must request a legibly dated

U.S. Postal Service postmark or obtain

a receipt from a commercial carrier or

the U.S. Postal Service. Private metered

postmarks will not be acceptable as

proof of timely mailing.)

2. Late Applicants: Applications that

do not meet the criteria in 1.(a) or 1.(b)

above are considered late applications.

Late applications will not be considered

in the current competition and will be

returned to the applicants.

Where to Obtain Additional

Information

To receive additional written

information call 1–888–GRANTS4. You

will be asked to leave your name,

address, and phone number and will

need to refer to NIOSH Announcement

98049. You will receive a complete

program description, information on

application procedures, and application

forms. CDC will not send application

kits by facsimile or express mail. Please

refer to NIOSH announcement 98049

when requesting information and

submitting an application.

If you have questions after reviewing

the contents of all the documents,

business management technical

assistance may be obtained from

Victoria Sepe, Grants Management

Specialist, Grants Management Branch,

Procurement and Grants Office, Centers

for Disease Control and Prevention

(CDC), Mailstop E–13, Room 321, 255

East Paces Ferry Road, NE., Atlanta, GA

30305, telephone (404) 842–6804,

Internet: vxw1@cdc.gov.

Programmatic technical assistance

may be obtained from Leslie Stayner,

Education and Information Division,

National Institute for Occupational

Safety and Health, Center for Disease

Control and Prevention (CDC), 4676

Columbia Parkway, Cincinnati, OH

45226, telephone (513) 533–8365, or

Internet address: lts2@cdc.gov.

This and other CDC announcements

are available through the CDC homepage

on the Internet. The address for the CDC

homepage is: http://www.cdc.gov.

Potential applicants may obtain a

copy of Healthy People 2000 (Full

Report, Stock No. 017–001–00474–0) or

Healthy People 2000 (Summary Report,

Stock No. 017–001–00473–1) through

the Superintendent of Documents,

Government Printing Office,

Washington, DC 20402–9325, telephone

(202) 512–1800.

NORA

The National Occupational Research

Agenda: copies of this publication may

be obtained from The National Institute

of Occupational Safety and Health,

Publications Office, 4676 Columbia

Parkway, Cincinnati, OH 45226–1998 or

phone 1–800–356–4674, and is available

through the NIOSH homepage, ‘‘http:/

www.cdc.gov/niosh/nora.html’’.

Reference Materials

Allen BC, Crump KS and Shipp AM

(1988). Correlation between

carcinogenic potency of chemicals in

animals and humans. Risk Analysis

8(4): 531–557.

Ames B.N. and Gold L.S. (1990).

Chemical carcinogenesis: Too many

rodent carcinogens. Proc. Natl. Acad.

Sci. 87;7772–7776.

Goodman G, and Wilson R. (1991).

Quantitative predictions of human

cancer risk from rodent carcinogenic

potencies: A closer look at the

epidemiological evidence for some

chemicals not definitively carcinogenic

in humans. Reg Tox and Pharm, 14;118–

146.

Stayner LT and Bailer AJ (1993).

Comparing toxicologic and

epidemiologic studies: Methylene

chloride—A case study. Risk Analysis,

13(6); 667–673.

Zeiss L. In Chemical Risk Assessment

and Occupational Health (1994).

Current Applications, Limitations and

Future Prospects. CM Smith, DC

Christiani and KT Kelsey eds. Auburn

House, Westport, Conn.

Dated: May 26, 1998.

Diane D. Porter,

Acting Director, National Institute For

Occupational Safety and Health, Centers for

Disease Control and Prevention (CDC).

[FR Doc. 98–14464 Filed 6–1–98; 8:45 am]

BILLING CODE 4163–19–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

Good Clinical Practices In

Investigational Product Research

Meeting

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice of meeting.

The Food and Drug Administration

(FDA) (Office of Regulatory Affairs, New

Orleans District Office) is announcing

the following meeting: ‘‘Good Clinical

Practices In Investigational Product

Research.’’ The topics to be discussed

are FDA regulatory requirements for the

conduct of investigational product

research and practical issues, such as,

how to prepare for a data audit, what to

expect during an investigation, and how

to get current information from FDA.

The purpose of this meeting is to

promote and encourage open dialogue

between FDA and professionals

involved in investigational product

research: Physicians, researchers,

research coordinators, nurses, allied

health professionals, and any other

interested parties.

Date and Time: The meeting will be

held on Friday, July 17, 1998;

registration from 7:45 a.m. to 8:30 a.m.;

meeting from 8:30 a.m. to 5 p.m.

Location: The meeting will be held at

the Louisiana State University Medical

Center, Medical Education Bldg.,

Lecture Room A, 1901 Perdido, New

Orleans, LA 70112.

Contact: Rebecca A. Asente, Food and

Drug Administration, New Orleans

District Office (HFR–SE440), 4298

Elysian Fields Ave., New Orleans, LA

70122, 504–589–6344, ext. 158, FAX

504–589–6360.

Registration: Send registration

information (including name, title, firm

name, address, telephone, and fax

number) to the contact person by

Friday, July 10, 1998. There is no

registration fee for this meeting.

Attendance will be limited to the first

200 applicants, therefore, interested

parties are encouraged to register early.

Priority will be given to those

individuals located in Louisiana and

Mississippi. Individuals located outside

these States may register to attend the

meeting and will be accepted if space is

available.

If you need special accommodations

due to a disability, please contact

Rebecca A. Asente at least 7 days in

advance.

Dated: May 21, 1998.

William K. Hubbard,

Associate Commissioner for Policy

Coordination.

[FR Doc. 98–14463 Filed 6–1–98; 8:45 am]

BILLING CODE 4160–01–F